Pfizer Gene Therapy Fails in Muscular Dystrophy Study bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Bellevue Group AG trimmed its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 1.8% during the fourth quarter, Holdings Channel reports. The fund owned 237,286 shares of the biotechnology company’s stock after selling 4,466 shares during the quarter. Bellevue Group AG’s holdings in Sarepta Therapeutics were worth $22,881,000 as of its most recent […]
Bellevue Group AG trimmed its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 1.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 237,286 shares of the biotechnology company’s stock after selling 4,466 shares during the […]
Eagle Asset Management Inc. lessened its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 0.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 216,168 shares of the biotechnology company’s stock after selling 2,054 shares during the quarter. Eagle Asset Management […]